|
Ivars Rubio A, Yufera JC, de la Morena P, Fernandez Sanchez A, Navarro Manzano E, Garcia Garre E, Garcia Martinez E, Marin Zafra G, Sanchez Canovas M, Garcia Torralba E, Ayala de la Pena F. Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables. Sci Rep. 2019 Nov 18;9(1):16979. doi: 10.1038/s41598-019-53606-3. PubMed PMID: 31740715; PubMed Central PMCID: PMC6861311.
AÑO: 2019; IF: 3.998
|
31740715
|
Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, Mata E, Biosca M, Custodio A, Espinosa J, Vazquez EG, Henao F, Ayala de la Pena F. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018). Clin Transl Oncol. 2019 Jan;21(1):75-86. doi: 10.1007/s12094-018-1983-4. Epub 2018 Nov 23. PubMed PMID: 30470991; PubMed Central PMCID: PMC6339667.
AÑO: 2019; IF: 2.737
|
|
Ayala de la Pena F, Andres R, Garcia-Saenz JA, Manso L, Margeli M, Dalmau E, Pernas S, Prat A, Servitja S, Ciruelos E. SEOM clinical guidelines in early stage breast cancer (2018). Clin Transl Oncol. 2019 Jan;21(1):18-30. doi: 10.1007/s12094-018-1973-6. Epub 2018 Nov 15. PubMed PMID: 30443868; PubMed Central PMCID: PMC6339657.
AÑO: 2019; IF: 2.737
|
|
Vera R, Otero MJ, Ayala de la Pena F, Gonzalez-Perez C, Penuelas A, Sepulveda JM, Quer N, Domenech-Climent N, Virizuela JA, Beorlegui P, Gorgas MQ. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Clin Transl Oncol. 2019 Apr;21(4):467-478. doi: 10.1007/s12094-018-1945-x. Epub 2018 Oct 8. PubMed PMID: 30298467.
AÑO: 2019; IF: 2.737
|
|
Luengo-Gil G, Garcia-Martinez E, Chaves-Benito A, Conesa-Zamora P, Navarro-Manzano E, Gonzalez-Billalabeitia E, Garcia-Garre E, Martinez-Carrasco A, Vicente V, Ayala de la Pena F. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Cell Oncol (Dordr). 2019 Oct;42(5):627-644. doi: 10.1007/s13402-019-00450-2. Epub 2019 May 21. PubMed PMID: 31115881.
AÑO: 2019; IF: 5.304
|